Billion-dollar deal takes UQ vaccine tech to the world
The University of Queensland’s Molecular Clamp technology has been acquired by global healthcare giant Sanofi in a landmark deal worth up to US$1.6 billion – the largest involving a company commercialising intellectual property from an Australian university. Sanofi entered into an agreement to acquire Vicebio, a company formed in 2018 to develop UQ’s proprietary Molecular…